Purpose Geographic atrophy (GA) is a late-stage form of age-related macular degeneration
(AMD) characterized by the expansion of atrophic lesions in the outer retina. There are …

Geographic atrophy (GA) is a progressive degenerative disease that significantly contributes
to visual impairment in individuals aged 50 years and older. The development of GA is …

Purpose To investigate the underlying reason for the previously observed impact of baseline
lesion size, number, and circularity on geographic atrophy (GA) growth rate. Design …

Purpose Classify the appearance and quantify the growth rate of chorioretinal atrophy in
patients who received voretigene neparvovec-rzyl (VN) for RPE65-mediated retinal …

Background/aims Best-corrected visual acuity (BCVA) is the most common primary endpoint
in treatment trials for choroideremia (CHM) but the long-term natural history of BCVA is …

Purpose To investigate the topographic distribution of geographic atrophy (GA) and to
identify an anatomic endpoint that correlates with visual acuity (VA) in eyes with GA. Design …

Purpose: The purpose of this study was to evaluate the long-term rate of progression and
baseline predictors of geographic atrophy (GA) using complete retinal pigment epithelium …

Purpose To investigate the progression of geographic atrophy secondary to nonneovascular
age-related macular degeneration in early and later stage lesions using artificial intelligence …

Age-related macular degeneration (AMD) is a disorder of the macula characterized in its
early and intermediate stages by the presence of drusen and pigmentary abnormalities in …

Geographic atrophy (GA) is currently an untreatable condition. Emerging evidence from
recent clinical trials show that anti-complement therapy may be a successful treatment …